NewEdge Advisors’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$249K Buy
17,638
+779
+5% +$11.5K ﹤0.01% 2470
2025
Q4
$239K Buy
16,859
+759
+5% +$11K ﹤0.01% 2475
2025
Q3
$238K Buy
16,100
+724
+5% +$10.8K ﹤0.01% 2316
2025
Q2
$233K Buy
+15,376
New +$225K ﹤0.01% 2145

Other funds holding BCAT

NewEdge Advisors's BCAT Position: Q1 2026 in Review

NewEdge Advisors increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 4.6% in Q1 2026, buying an estimated $11.5K and bringing the position to 17,638 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #2470.

NewEdge Advisors first reported a position in BCAT in Q2 2025 and has held it in 4 quarters since. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.

  • NewEdge Advisors held 17,638 shares of BlackRock Capital Allocation Term Trust worth $249K as of Q1 2026.
  • NewEdge Advisors bought 779 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $11.5K.
  • BlackRock Capital Allocation Term Trust made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #2470 holding.
  • NewEdge Advisors first reported a position in BlackRock Capital Allocation Term Trust in Q2 2025 and has held it in 4 quarters since.
  • 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.

Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.